These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion. McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395 [TBL] [Abstract][Full Text] [Related]
9. Ex vivo perfusion of mouse hearts expressing the human complement regulatory protein CD59. Harland RC; Logan JS; Kooyman D; Byrne GW; Platt JL Transplant Proc; 1994 Jun; 26(3):1245. PubMed ID: 7518120 [No Abstract] [Full Text] [Related]
10. Difference of expression levels between gene technological product delta CYT-MCP(CD46) and intact MCP(CD46) in transgenic mice. Miyagawa S; Ikawa M; Kominami K; Yoshimura Y; Tanaka H; Mikata S; Shirakura R; Matsuda H; Yanagi Y; Seya T; Okabe M Transplant Proc; 1996 Apr; 28(2):585-6. PubMed ID: 8623285 [No Abstract] [Full Text] [Related]
11. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF. Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143 [No Abstract] [Full Text] [Related]
12. Mice transgenic for human CD46 and CD55 are protected from human complement attack. Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403 [No Abstract] [Full Text] [Related]
13. Comparative analysis of human DAF expression in the tissues of transgenic pigs and man. Cozzi E; Langford GA; Wright L; Tucker A; Yannoutsos N; Richards A; Rosengard A; Elsome K; Lancaster R; White DJ Transplant Proc; 1995 Feb; 27(1):319-20. PubMed ID: 7533397 [No Abstract] [Full Text] [Related]
14. Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis. Charreau B; Cassard A; Tesson L; Le Mauff B; Blanchard D; Lublin D; Soulillou JP; Anegon I Transplant Proc; 1995 Feb; 27(1):336-7. PubMed ID: 7533404 [No Abstract] [Full Text] [Related]
15. Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model. Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Melli C; Bruzzone P; Alfani D Transplant Proc; 1996 Apr; 28(2):589. PubMed ID: 8623287 [No Abstract] [Full Text] [Related]
16. Production of pigs transgenic for human decay accelerating factor. Langford GA; Yannoutsos N; Cozzi E; Lancaster R; Elsome K; Chen P; Richards A; White DJ Transplant Proc; 1994 Jun; 26(3):1400-1. PubMed ID: 7518134 [No Abstract] [Full Text] [Related]
17. Functional expression of human CD59 in transgenic mice. Somerville CA; Kyriazis AG; McKenzie A; Allison J; Pearse MJ; D'Apice AJ Transplantation; 1994 Dec; 58(12):1430-5. PubMed ID: 7528953 [No Abstract] [Full Text] [Related]
18. In vivo evaluation of human membrane cofactor protein in transgenic mice. IJzermans JN; Schraa EO; Bonthuis F; Yannnoutsos N; Marquet RL Transplant Proc; 1996 Apr; 28(2):671-2. PubMed ID: 8623336 [No Abstract] [Full Text] [Related]
19. Protection from complement-mediated cytolysis in cross-species hepatocytes transfected with complement regulatory factor (HRF20) using retroviral vector. Hayashi S; Isobe K; Emi N; Kasai Y; Yokoyama I; Takagi H Transplant Proc; 1994 Jun; 26(3):1252. PubMed ID: 7518121 [No Abstract] [Full Text] [Related]
20. Expression of human decay accelerating factor in transgenic pigs. Cozzi E; Langford GA; Richards A; Elsome K; Lancaster R; Chen P; Yannoutsos N; White DJ Transplant Proc; 1994 Jun; 26(3):1402-3. PubMed ID: 7518135 [No Abstract] [Full Text] [Related] [Next] [New Search]